Takeda, Scripps Research Institute deal

Takeda and Scripps expanded a 2010 discovery deal to include additional undisclosed targets in new undisclosed therapeutic areas. The partners are using the institute's high throughput screening technology to discover compounds against undisclosed targets from Takeda. ...